Jan. 13 at 4:50 PM
$CNXC: Concentrix returned to EPS upside in Q4, but softer FY26 margin guidance weighed. Progress in higher-value, tech-enabled work is encouraging. However, investors want clearer evidence that margin recovery is taking hold. Get all the details here: https://www.briefing.com/story-stocks/archive/2026/1/13/concentrix-returns-to-eps-upside-in-q4-but-mixed-fy26-guidance-weighs-(cnxc)?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link